Evaluation of Enoxaparin Dosing in Hospitalized Morbidly Obese Patients at an Academic Medical Center
Phase of Trial: Phase IV
Latest Information Update: 16 Dec 2017
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Apr 2017 Status changed from recruiting to completed.
- 11 Apr 2016 Planned End Date changed from 1 Mar 2014 to 1 Mar 2018.